Identifying mechanisms of Epimedii Folium against Alzheimer’s disease a network pharmacology approach Epimedii Folium treats Alzheimer’s disease PI3K-AKT
To elucidate the mechanism of the multi-target action of Epimedii Folium on Alzheimer’s disease, this study focuses on the analysis of network pharmacology. Based on a bioinformatics approach, this study obtained the effective components of Epimedium through the Traditional Chinese Medicine Systems...
Guardado en:
Autores principales: | , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
SAGE Publishing
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a2aef3f835c44bb8b9cb67a374f3bf14 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:a2aef3f835c44bb8b9cb67a374f3bf14 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:a2aef3f835c44bb8b9cb67a374f3bf142021-11-19T23:03:58ZIdentifying mechanisms of Epimedii Folium against Alzheimer’s disease a network pharmacology approach Epimedii Folium treats Alzheimer’s disease PI3K-AKT2058-739210.1177/20587392211041435https://doaj.org/article/a2aef3f835c44bb8b9cb67a374f3bf142021-11-01T00:00:00Zhttps://doi.org/10.1177/20587392211041435https://doaj.org/toc/2058-7392To elucidate the mechanism of the multi-target action of Epimedii Folium on Alzheimer’s disease, this study focuses on the analysis of network pharmacology. Based on a bioinformatics approach, this study obtained the effective components of Epimedium through the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform, predicted the compound targets through the Pharmapper and Swiss target prediction database and then through Gene Expression Omnibus Datasets and Therapeutic Target Database. We collected and analysed of heral and disease targets, constructed the network. Through the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway, Gene Ontology enrichment, then the key targets and pathways of Epimedii Folium to cope with Alzheimer’s disease have been identified. Twenty-three bioactive components and 477 potential target genes of Epimedii Folium were identified. A total of 1612 target diseases were identified. Through network module analysis, 30 hub target genes were identified. Through enrichment analysis of the KEGG pathway, hub target genes were largely enriched in the PI3K-AKT signaling pathway. Through the analysis of network pharmacology, it was found that Epimedii Folium might play the role of multi-compound and multi-target therapy through the PI3K-AKT signaling pathway. These findings provide helpful directions for future clinical studies.Yan ZhaoGuangmei LiuYang YangLing ChenYing ShangQian HongSAGE PublishingarticleMedicineRENEuropean Journal of Inflammation, Vol 19 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R |
spellingShingle |
Medicine R Yan Zhao Guangmei Liu Yang Yang Ling Chen Ying Shang Qian Hong Identifying mechanisms of Epimedii Folium against Alzheimer’s disease a network pharmacology approach Epimedii Folium treats Alzheimer’s disease PI3K-AKT |
description |
To elucidate the mechanism of the multi-target action of Epimedii Folium on Alzheimer’s disease, this study focuses on the analysis of network pharmacology. Based on a bioinformatics approach, this study obtained the effective components of Epimedium through the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform, predicted the compound targets through the Pharmapper and Swiss target prediction database and then through Gene Expression Omnibus Datasets and Therapeutic Target Database. We collected and analysed of heral and disease targets, constructed the network. Through the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway, Gene Ontology enrichment, then the key targets and pathways of Epimedii Folium to cope with Alzheimer’s disease have been identified. Twenty-three bioactive components and 477 potential target genes of Epimedii Folium were identified. A total of 1612 target diseases were identified. Through network module analysis, 30 hub target genes were identified. Through enrichment analysis of the KEGG pathway, hub target genes were largely enriched in the PI3K-AKT signaling pathway. Through the analysis of network pharmacology, it was found that Epimedii Folium might play the role of multi-compound and multi-target therapy through the PI3K-AKT signaling pathway. These findings provide helpful directions for future clinical studies. |
format |
article |
author |
Yan Zhao Guangmei Liu Yang Yang Ling Chen Ying Shang Qian Hong |
author_facet |
Yan Zhao Guangmei Liu Yang Yang Ling Chen Ying Shang Qian Hong |
author_sort |
Yan Zhao |
title |
Identifying mechanisms of Epimedii Folium against Alzheimer’s disease a network pharmacology approach Epimedii Folium treats Alzheimer’s disease PI3K-AKT |
title_short |
Identifying mechanisms of Epimedii Folium against Alzheimer’s disease a network pharmacology approach Epimedii Folium treats Alzheimer’s disease PI3K-AKT |
title_full |
Identifying mechanisms of Epimedii Folium against Alzheimer’s disease a network pharmacology approach Epimedii Folium treats Alzheimer’s disease PI3K-AKT |
title_fullStr |
Identifying mechanisms of Epimedii Folium against Alzheimer’s disease a network pharmacology approach Epimedii Folium treats Alzheimer’s disease PI3K-AKT |
title_full_unstemmed |
Identifying mechanisms of Epimedii Folium against Alzheimer’s disease a network pharmacology approach Epimedii Folium treats Alzheimer’s disease PI3K-AKT |
title_sort |
identifying mechanisms of epimedii folium against alzheimer’s disease a network pharmacology approach epimedii folium treats alzheimer’s disease pi3k-akt |
publisher |
SAGE Publishing |
publishDate |
2021 |
url |
https://doaj.org/article/a2aef3f835c44bb8b9cb67a374f3bf14 |
work_keys_str_mv |
AT yanzhao identifyingmechanismsofepimediifoliumagainstalzheimersdiseaseanetworkpharmacologyapproachepimediifoliumtreatsalzheimersdiseasepi3kakt AT guangmeiliu identifyingmechanismsofepimediifoliumagainstalzheimersdiseaseanetworkpharmacologyapproachepimediifoliumtreatsalzheimersdiseasepi3kakt AT yangyang identifyingmechanismsofepimediifoliumagainstalzheimersdiseaseanetworkpharmacologyapproachepimediifoliumtreatsalzheimersdiseasepi3kakt AT lingchen identifyingmechanismsofepimediifoliumagainstalzheimersdiseaseanetworkpharmacologyapproachepimediifoliumtreatsalzheimersdiseasepi3kakt AT yingshang identifyingmechanismsofepimediifoliumagainstalzheimersdiseaseanetworkpharmacologyapproachepimediifoliumtreatsalzheimersdiseasepi3kakt AT qianhong identifyingmechanismsofepimediifoliumagainstalzheimersdiseaseanetworkpharmacologyapproachepimediifoliumtreatsalzheimersdiseasepi3kakt |
_version_ |
1718419853785694208 |